carbidopa/levodopa fairmed 25 mg / 250 mg tabletti
fairmed healthcare gmbh - carbidopa monohydrate, levodopa - tabletti - 25 mg / 250 mg - levodopa ja dekarboksylaasin estäjä
carbidopa/levodopa fairmed 25 mg / 100 mg tabletti
fairmed healthcare gmbh - carbidopa monohydrate, levodopa - tabletti - 25 mg / 100 mg - levodopa ja dekarboksylaasin estäjä
carbidopa/levodopa fairmed 12,5 mg / 50 mg tabletti
fairmed healthcare gmbh - carbidopa monohydrate, levodopa - tabletti - 12,5 mg / 50 mg - levodopa ja dekarboksylaasin estäjä
carbidopa/levodopa fairmed 10 mg / 100 mg tabletti
fairmed healthcare gmbh - carbidopa monohydrate, levodopa - tabletti - 10 mg / 100 mg - levodopa ja dekarboksylaasin estäjä
vancomycin strides 125 mg kapseli, kova
strides pharma (cyprus) limited - vancomycin hydrochloride - kapseli, kova - 125 mg - vankomysiini
vancomycin strides 250 mg kapseli, kova
strides pharma (cyprus) limited - vancomycin hydrochloride - kapseli, kova - 250 mg - vankomysiini
gabapentin strides 400 mg kapseli, kova
strides pharma (cyprus) limited - gabapentin - kapseli, kova - 400 mg - gabapentiini
gabapentin strides 300 mg kapseli, kova
strides pharma (cyprus) limited - gabapentin - kapseli, kova - 300 mg - gabapentiini
gabapentin strides 100 mg kapseli, kova
strides pharma (cyprus) limited - gabapentin - kapseli, kova - 100 mg - gabapentiini
kauliv
strides pharma (cyprus) limited - teriparatidi - osteoporosis; osteoporosis, postmenopausal - kalsiumin homeostaasi - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.